Trials / Completed
CompletedNCT03372161
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 401 (actual)
- Sponsor
- Scilex Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a research study of SP-102, an experimental medication designed to relieve pain in patients with a specific type of leg pain. The medication is given once by your healthcare professional, with a possibility of a second injection as early as about 1 month after the first treatment. The purpose of the study is to measure how well a single injection of the experimental medication, SP-102, relieves pain. The study will also investigate the side effects of SP-102.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SP-102 | injection |
| DRUG | Placebo | injection |
Timeline
- Start date
- 2017-12-08
- Primary completion
- 2021-08-20
- Completion
- 2022-01-06
- First posted
- 2017-12-13
- Last updated
- 2022-09-19
- Results posted
- 2022-09-19
Locations
37 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03372161. Inclusion in this directory is not an endorsement.